Target Price | $387.05 |
Price | $329.91 |
Potential | 17.32% |
Number of Estimates | 21 |
21 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $387.05. This is 17.32% higher than the current stock price. The highest price target is $420.00 27.31% , the lowest is $300.00 9.07% . | |
A rating was issued by 30 analysts: 16 Analysts recommend Sherwin-Williams to buy, 11 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 17.32% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
23 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.7b . This is 2.59% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.0b 4.00% , the lowest is $23.1b 0.05% .
This results in the following potential growth metrics:
2024 | $23.1b | 0.20% |
---|---|---|
2025 | $23.7b | 2.59% |
2026 | $24.9b | 4.95% |
2027 | $26.3b | 5.66% |
2028 | $27.2b | 3.61% |
24 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.7b . This is 7.83% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.0b 13.75% , the lowest is $4.6b 4.25% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $4.4b | 3.63% |
---|---|---|
2025 | $4.7b | 7.99% |
2026 | $5.2b | 9.16% |
2027 | $5.6b | 8.92% |
2028 | $5.7b | 1.08% |
2024 | 19.04% | 3.42% |
---|---|---|
2025 | 20.04% | 5.24% |
2026 | 20.85% | 4.04% |
2027 | 21.49% | 3.07% |
2028 | 20.97% | 2.42% |
11 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.9b . This is 8.43% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 15.17% , the lowest is $2.7b 0.95% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.7b | 14.05% |
---|---|---|
2025 | $2.9b | 8.43% |
2026 | $3.2b | 12.88% |
2027 | $3.7b | 13.38% |
2028 | $3.8b | 3.55% |
2024 | 11.48% | 13.82% |
---|---|---|
2025 | 12.13% | 5.68% |
2026 | 13.05% | 7.58% |
2027 | 14.00% | 7.28% |
2028 | 13.99% | 0.07% |
11 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.44 . This is 8.44% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.15 15.17% , the lowest is $10.65 0.95% .
This results in the following potential growth metrics and future valuations:
2024 | $10.55 | 14.05% |
---|---|---|
2025 | $11.44 | 8.44% |
2026 | $12.91 | 12.85% |
2027 | $14.64 | 13.40% |
2028 | $15.16 | 3.55% |
Current | 31.28 | 12.92% |
---|---|---|
2025 | 29.40 | 7.78% |
2026 | 26.04 | 11.43% |
2027 | 22.97 | 11.79% |
2028 | 22.18 | 3.44% |
Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.10 and an P/S ratio of 3.57 .
This results in the following potential growth metrics and future valuations:
Current | 4.14 | 0.48% |
---|---|---|
2025 | 4.10 | 2.54% |
2026 | 3.91 | 4.71% |
2027 | 3.70 | 5.36% |
2028 | 3.57 | 3.49% |
Current | 3.59 | 1.79% |
---|---|---|
2025 | 3.57 | 2.53% |
2026 | 3.40 | 4.72% |
2027 | 3.22 | 5.36% |
2028 | 3.11 | 3.49% |
Sherwin-Williams...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 09 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 08 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 07 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 03 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 01 2025 |
Jefferies |
Buy
➜
Hold
|
Downgrade | Mar 10 2025 |
Citigroup |
➜
Buy
|
Unchanged | Feb 26 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 09 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 08 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 07 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 03 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Apr 01 2025 |
Downgrade
Jefferies:
Buy
➜
Hold
|
Mar 10 2025 |
Unchanged
Citigroup:
➜
Buy
|
Feb 26 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.